# Niclosamide With Etanercept in Rheumatoid Arthritis

> **NCT03160001** · PHASE1,PHASE2 · COMPLETED · sponsor: **Faiq Gorial** · enrollment: 110 (actual)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** Placebo
- **DRUG:** Niclosamide
- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT03160001
- **Lead sponsor:** Faiq Gorial
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-15
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-12-10
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2018-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03160001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03160001, "Niclosamide With Etanercept in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03160001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*